| Name | Steward Organization | Suggested Domain | Suggested Domain Description | Cde Group | Classification |
|---|---|---|---|---|---|
| diacyl PtdCho 16:0/20:4; 18:1/18:3; 14:0/22:4; 18:2/18:2; 16:1/20:3 | ADNI | Biomarkers, genetics, and genomics |
Biomarkers, genetics, and genomics relevant to AD/ADRD |
Other NIA-funded studies |
|
| # | Datatype |
|---|---|
|
|
Text |
| # | Identifier | Origin | Version |
|---|---|---|---|
|
|
NOPHASE_AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios_ADMCPDIPESIPCISRATIOS_PC.36.4_NODD_CRF_VERSION | ADNI-PHASE+CRFNAME+TBLNAME+FLDNAME+DD_CRF_VERSION | ADNI_01-12-2025 |